Compounds > dmp 323

Page last updated: 2024-08-25

dmp 323 and ritonavir

dmp 323 has been researched along with ritonavir in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (71.43)	18.2507
2000's	2 (28.57)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akamike, E; Cheatham, WW; Collins, RD; DeLucca, I; Hollis, AY; Lam, PY; Ru, Y; Wilkerson, WW	1
Ala, P; Anton, ED; Bacheler, LT; Chang, CH; Garber, SS; Jadhav, PK; Woerner, FJ	1
Cheatham, WW; Dax, S; Wilkerson, WW	1
Anderson, PS; Bacheler, LT; Chang, CH; Cordova, B; Erickson-Viitanen, S; Garber, S; Johnson, BL; Klabe, RM; Ko, SS; Lam, PY; Li, R; Reid, C; Rodgers, JD; Ru, Y; Seitz, SP; Trainor, GL; Wang, H; Wright, MR	1
Danielson, UH; Hallberg, A; Hämäläinen, M; Karlén, A; Markgren, PO; Samuelsson, B; Schaal, W	1
Bacheler, LT; Cordova, B; De Lucca, GV; Erickson-Viitanen, S; Garber, S; Kim, UT; Klabe, RM; Ko, SS; Lam, GN; Liang, J; Logue, KA; Trainor, GL; Wright, MR	1
Gyémánt, N; Hilgeroth, A; Molnár, J; Richter, M	1

Other Studies

7 other study(ies) available for dmp 323 and ritonavir

Article	Year
HIV protease inhibitory bis-benzamide cyclic ureas: a quantitative structure-activity relationship analysis. Journal of medicinal chemistry, 1996, Oct-11, Volume: 39, Issue:21 Topics: Anti-HIV Agents; Benzamides; Chromatography, High Pressure Liquid; HIV Protease Inhibitors; HIV-1; Kinetics; RNA, Viral; Structure-Activity Relationship; Urea; Virus Replication	1996
Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV. Journal of medicinal chemistry, 1997, Jan-17, Volume: 40, Issue:2 Topics: Amides; Anti-HIV Agents; Cells, Cultured; Crystallography, X-Ray; Drug Resistance, Microbial; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Mutation; Protein Conformation; Sensitivity and Specificity; Urea	1997
Nonsymmetrically substituted cyclic urea HIV protease inhibitors. Journal of medicinal chemistry, 1997, Dec-05, Volume: 40, Issue:25 Topics: Anti-HIV Agents; HIV Protease Inhibitors; RNA, Viral; Structure-Activity Relationship; Urea	1997
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors. Chemistry & biology, 1998, Volume: 5, Issue:10 Topics: Animals; Anti-HIV Agents; Crystallography, X-Ray; Dogs; Drug Design; HIV; HIV Protease Inhibitors; Molecular Structure; Mutation; Protein Binding; Urea; Virus Replication	1998
Relationships between structure and interaction kinetics for HIV-1 protease inhibitors. Journal of medicinal chemistry, 2002, Dec-05, Volume: 45, Issue:25 Topics: Biosensing Techniques; HIV Protease; HIV Protease Inhibitors; Kinetics; Protein Binding; Structure-Activity Relationship; Surface Plasmon Resonance; Urea	2002
Nonsymmetric P2/P2' cyclic urea HIV protease inhibitors. Structure-activity relationship, bioavailability, and resistance profile of monoindazole-substituted P2 analogues. Journal of medicinal chemistry, 1998, Jun-18, Volume: 41, Issue:13 Topics: Administration, Oral; Animals; Anti-HIV Agents; Azepines; Biological Availability; Cell Line; Chromatography, High Pressure Liquid; Dogs; Drug Design; Drug Resistance, Microbial; HIV Protease Inhibitors; HIV-1; Indazoles; Mutation; Ritonavir; RNA, Viral; Structure-Activity Relationship; Transcription, Genetic; Urea	1998
P-glycoprotein effects of cyclic urea HIV protease inhibitor DMP 323 in competitional absorption studies. Archiv der Pharmazie, 2006, Volume: 339, Issue:11 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Azepines; Cell Line, Tumor; HIV Protease Inhibitors; Intestinal Absorption; Male; Mice; Permeability; Rats; Rats, Wistar; Ritonavir; Urea	2006